Zubin J. Eapen

6.7k total citations · 1 hit paper
67 papers, 3.0k citations indexed

About

Zubin J. Eapen is a scholar working on Cardiology and Cardiovascular Medicine, Economics and Econometrics and Emergency Medicine. According to data from OpenAlex, Zubin J. Eapen has authored 67 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Cardiology and Cardiovascular Medicine, 12 papers in Economics and Econometrics and 11 papers in Emergency Medicine. Recurrent topics in Zubin J. Eapen's work include Heart Failure Treatment and Management (37 papers), Cardiovascular Function and Risk Factors (11 papers) and Medication Adherence and Compliance (9 papers). Zubin J. Eapen is often cited by papers focused on Heart Failure Treatment and Management (37 papers), Cardiovascular Function and Risk Factors (11 papers) and Medication Adherence and Compliance (9 papers). Zubin J. Eapen collaborates with scholars based in United States, United Kingdom and Canada. Zubin J. Eapen's co-authors include Larry A. Allen, Adrian F. Hernandez, Colleen K. McIlvennan, Gregg C. Fonarow, Paul A. Heidenreich, Eric D. Peterson, Clyde W. Yancy, Deepak L. Bhatt, Javed Butler and Lesley H. Curtis and has published in prestigious journals such as JAMA, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Zubin J. Eapen

63 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hospital Readmissions Reduction Program

2015 510 citations Zubin J. Eapen, Larry A. Allen et al. Circulation profile →

Peers

Countries citing papers authored by Zubin J. Eapen

Since Specialization

Citations

This map shows the geographic impact of Zubin J. Eapen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zubin J. Eapen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zubin J. Eapen more than expected).

Fields of papers citing papers by Zubin J. Eapen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zubin J. Eapen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zubin J. Eapen. The network helps show where Zubin J. Eapen may publish in the future.

Co-authorship network of co-authors of Zubin J. Eapen

This figure shows the co-authorship network connecting the top 25 collaborators of Zubin J. Eapen. A scholar is included among the top collaborators of Zubin J. Eapen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zubin J. Eapen. Zubin J. Eapen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract 14740: Achieving Guideline-Directed Therapy in U.S. Patients With Diabetes and Cardiovascular Disease: Alarming Gaps, Compelling Opportunities 2019 ·Circulation ·Maddalena Ardissino, Adam J. Nelson, Kevin Haynes, Zubin J. Eapen, (unknown), Anthony Carnicelli, Emily C. O’Brien, Renato D. Lópes, Jennifer Green, Darren K. McGuire, Neha J. Pagidipati, Christopher B. Granger	2
2	Utilizing mobile technologies to improve physical activity and medication adherence in patients with heart failure and diabetes mellitus: Rationale and design of the TARGET-HF-DM Trial 2019 ·American Heart Journal ·Abhinav Sharma, Robert J. Mentz, Bradi B. Granger, John F. Heitner, Lauren B. Cooper, Dipanjan Banerjee, Cynthia L. Green, (unknown), Zubin J. Eapen, Lori L. Hudson, G. Michael Felker	31
3	Moving Beyond the Walls of the Clinic 2017 ·JACC Heart Failure ·(unknown), Zubin J. Eapen, Mark McClellan	25
4	Text2PreventCVD: protocol for a systematic review and individual participant data meta-analysis of text message-based interventions for the prevention of cardiovascular diseases 2016 ·BMJ Open ·Clara K Chow, Sheikh Mohammed Shariful Islam, Andrew Farmer, Kirsty Bobrow, (unknown), Robyn Whittaker, Leila Pfaeffli Dale, Andreas Lechner, Louis Niessen, Scott A. Lear, Zubin J. Eapen, Karla Santo, Sandrine Stepien, Julie Redfern, Anthony Rodgers	15
5	Has Public Reporting of Hospital Readmission Rates Affected Patient Outcomes? 2016 ·Journal of the American College of Cardiology ·Adam D. DeVore, Bradley G. Hammill, N. Chantelle Hardy, Zubin J. Eapen, Eric D. Peterson, Adrian F. Hernandez	39
6	Precipitating Clinical Factors, Heart Failure Characterization, and Outcomes in Patients Hospitalized With Heart Failure With Reduced, Borderline, and Preserved Ejection Fraction 2016 ·JACC Heart Failure ·John R Kapoor, Roger Kapoor, Christine Ju, Paul A. Heidenreich, Zubin J. Eapen, Adrian F. Hernandez, Javed Butler, Clyde W. Yancy, Gregg C. Fonarow	182
7	TEMPORAL TRENDS IN CARE AND OUTCOMES OF PATIENTS RECEIVING FIBRINOLYTIC THERAPY COMPARED TO PRIMARY PERCUTANEOUS CORONARY INTERVENTION IN THE GET WITH THE GUIDELINES CORONARY ARTERY DISEASE (GWTG-CAD) REGISTRY 2015 ·Journal of the American College of Cardiology ·Ravi S. Hira, Deepak L. Bhatt, Gregg C. Fonarow, Paul A. Heidenreich, Christine Ju, Salim S. Virani, Adrian F. Hernandez, Lee H. Schwamm, Zubin J. Eapen, Michelle A. Albert, (unknown), Hani Jneid	0
8	Thinking Outside the Box: Treating Acute Heart Failure Outside the Hospital to Improve Care and Reduce Admissions 2015 ·Journal of Cardiac Failure ·Adam D. DeVore, Larry A. Allen, Zubin J. Eapen	17
9	Trends in the Use and Outcomes of Ventricular Assist Devices Among Medicare Beneficiaries, 2006 Through 2011 2014 ·Journal of the American College of Cardiology ·Prateeti Khazanie, Bradley G. Hammill, Chetan B. Patel, Zubin J. Eapen, Eric D. Peterson, Joseph G. Rogers, Carmelo A. Milano, Lesley H. Curtis, Adrian F. Hernandez	48
10	Current quality of cardiovascular prevention for Million Hearts: An analysis of 147,038 outpatients from The Guideline Advantage 2014 ·American Heart Journal ·Zubin J. Eapen, Li Liang, Jay H. Shubrook, Mary Ann Bauman, Vincent J. Bufalino, Deepak L. Bhatt, Eric D. Peterson, Adrian F. Hernandez	23
11	An Evaluation of Mobile Health Application Tools 2014 ·JMIR mhealth and uhealth ·(unknown), Zubin J. Eapen, Kevin P. Weinfurt, Bimal R. Shah, Kevin A. Schulman	155
12	Associations between atrial fibrillation and early outcomes of patients with heart failure and reduced or preserved ejection fraction 2013 ·American Heart Journal ·Zubin J. Eapen, Melissa A. Greiner, Gregg C. Fonarow, Žhong Yuan, Roger M. Mills, Adrian F. Hernandez, Lesley H. Curtis	51
13	Clinical Effectiveness of Anticoagulation Therapy Among Older Patients With Heart Failure and Without Atrial Fibrillation: Findings From the ADHERE Registry Linked to Medicare Claims 2013 ·Journal of Cardiac Failure ·Adrian F. Hernandez, Bradley G. Hammill, Robb D. Kociol, Zubin J. Eapen, Gregg C. Fonarow, Winslow Klaskala, Roger M. Mills, Lesley H. Curtis	6
14	Validated, Electronic Health Record Deployable Prediction Models for Assessing Patient Risk of 30-Day Rehospitalization and Mortality in Older Heart Failure Patients 2013 ·JACC Heart Failure ·Zubin J. Eapen, Li Liang, Gregg C. Fonarow, Paul A. Heidenreich, Lesley H. Curtis, Eric D. Peterson, Adrian F. Hernandez	96
15	Relationship between sex, ejection fraction, and B-type natriuretic peptide levels in patients hospitalized with heart failure and associations with inhospital outcomes: Findings from the Get With The Guideline–Heart Failure Registry 2013 ·American Heart Journal ·Eileen Hsich, Maria V. Grau‐Sepulveda, Adrian F. Hernandez, Zubin J. Eapen, Ying Xian, Lee H. Schwamm, Deepak L. Bhatt, Gregg C. Fonarow	57
16	Adherence and Persistence in the Use of Warfarin After Hospital Discharge Among Patients With Heart Failure and Atrial Fibrillation 2013 ·Journal of Cardiac Failure ·Zubin J. Eapen, Xiaojuan Mi, Laura G. Qualls, Bradley G. Hammill, Gregg C. Fonarow, Mintu P. Turakhia, Paul A. Heidenreich, Eric D. Peterson, Lesley H. Curtis, Adrian F. Hernandez, Sana M. Al‐Khatib	19
17	DO COUNTRIES OR HOSPITALS WITH LONGER STAYS HAVE LOWER READMISSION RATES? FINDINGS FROM THE ASCEND-HF TRIAL 2012 ·Journal of the American College of Cardiology ·Zubin J. Eapen, Shelby D. Reed, Yanhong Li, Paul W. Armstrong, (unknown), John J.V. McMurray, Barry M. Massie, Karl Swedberg, Justin A. Ezekowitz, Gregg C. Fonarow, John R. Teerlink, Marco Metra, David J. Whellan, (unknown), Robert M. Califf, Adrian F. Hernandez	2
18	Predicting Costs Among Medicare Beneficiaries With Heart Failure 2011 ·The American Journal of Cardiology ·Melissa A. Greiner, Bradley G. Hammill, Gregg C. Fonarow, David J. Whellan, Zubin J. Eapen, Adrian F. Hernandez, Lesley H. Curtis	28
19	Quality of care for sudden cardiac arrest: Proposed steps to improve the translation of evidence into practice 2011 ·American Heart Journal ·Zubin J. Eapen, Eric D. Peterson, Gregg C. Fonarow, Gillian D Sanders, Clyde W. Yancy, Samuel F. Sears, Mark D. Carlson, Anne B. Curtis, Laura Lee Hall, David L. Hayes, Adrian F. Hernandez, Michael Mirro, Eric N. Prystowsky, Andrea M. Russo, Kevin L. Thomas, Sana M. Al‐Khatib	8
20	Strategies to attenuate pathological remodeling in heart failure 2009 ·Current Opinion in Cardiology ·Zubin J. Eapen, Joseph G. Rogers	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact